Siegfried Holding AG (SFZN.SW)

933,00 +6,00 (+0,65%) Börsenschluss: 05:30PM CEST

Siegfried Holding AG

Untere Bruehlstrasse 4
Zofingen 4800
Switzerland
41 62 746 1111
https://www.siegfried.ch

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 3.819

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Reto Suter Ph.D.	Interim CEO & CFO	N/A	N/A	1971
Dr. Jurgen Roos Ph.D.	Chief Scientific Officer	N/A	N/A	1968
Dr. Luca Dalla Torre	General Counsel & Secretary	N/A	N/A	N/A
Mr. Peter Stierli	Head of Corporate Communications	N/A	N/A	N/A
Ms. Irene Wosgien	Chief Human Resources Officer	N/A	N/A	1973
Ms. Marianne Spane	Chief Business Officer of Drug Substances & Drug Products	N/A	N/A	1962
Mr. Enno Schweinberger Ph.D.	Head Global Quality Management DS - Zofingen	N/A	N/A	N/A
Daniel Nieper	Chief Strategy Officer	N/A	N/A	N/A
Mr. Marcel Imwinkelried	Chief Operating Officer Drug Products	N/A	N/A	1967
Beatrice Harder	Head Regulatory Affairs - Site Zofingen	N/A	N/A	N/A

Die Beträge haben den Stand und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in CHF.

Beschreibung

Siegfried Holding AG, together with its subsidiaries, provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. It offers pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale-up and clinical trial material production services. The company develops and produces APIs and intermediates, as well as finished dosage forms, including solid oral dosage forms, sterile and aseptic filling injectables, ophthalmics, and inhalative products. In addition, it provides APIs and controlled substances focusing on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition; exclusive synthesis services comprising process and chemical development, analytical development, pilot manufacturing and scale-up, and commercial manufacturing; and viral vector manufacturing solutions. Further, the company licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for products. Siegfried Holding AG was founded in 1873 and is headquartered in Zofingen, Switzerland.

Corporate Governance

Siegfried Holding AGs ISS Governance QualityScore, Stand 1. Juni 2024, lautet 5. Die grundlegenden Scores sind Audit: 2, Vorstand: 3, Shareholderrechte: 1, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.